Metabolism and Pharmacokinetics of Oral Solution of [14C]-BI 201335 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of the Effect of BI 201335 on the QT Interval in Healthy Female and Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Tolerability Study of BIBF 1120 as Intravenous Infusion and Absolute Bioavailability of BIBF 1120 as Soft Gelatine Capsule in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2